Related Experiment Video
Updated: May 20, 2026

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
Expression of the PTTG1 oncogene is associated with aggressive clear cell renal cell carcinoma
Bill Wondergem1, Zhongfa Zhang, Dachuan Huang
1Laboratories of Cancer Genetics, Cytogenetics, and Computational Biology, Van Andel Research Institute; Department of Urology, Spectrum Health Hospital, Grand Rapids, MI 49503, USA.
Abstract:
The pituitary tumor transforming gene (PTTG1) is a recently discovered oncogene implicated in malignant progression of both endocrine and nonendocrine malignancies. Clear cell renal cell carcinoma (ccRCC) is cytogenetically characterized by chromosome 3p deletions that harbor the ccRCC-related von Hippel-Lindau, PBRM1, BAP1, and SETD2 tumor suppressor genes, along with chromosome 5q amplifications where the significance has been unclear. PTTG1 localizes to the chromosome 5q region where amplifications occur in ccRCC. In this study, we report a functional role for PTTG1 in ccRCC tumorigenesis. PTTG1 was amplified in ccRCC, overexpressed in tumor tissue, and associated with high-grade tumor cells and poor patient prognosis. In preclinical models, PTTG1 ablation reduced tumorigenesis and invasion. An analysis of gene expression affected by PTTG1 indicated an association with invasive and metastatic disease. PTTG1-dependent expression of the RhoGEF proto-oncogene ECT2 was observed in a number of ccRCC cell lines. Moreover, ECT2 expression correlated with PTTG1 expression and poor clinical features. Together, our findings reveal features of PTTG1 that are consistent with its identification of an oncogene amplified on chromsome 5q in ccRCC, where it may offer a novel therapeutic target of pathologic significance in this disease.
Insights
The pituitary tumor transforming gene (PTTG1) is amplified and overexpressed in clear cell renal cell carcinoma (ccRCC), promoting tumor growth and invasion. PTTG1 may represent a novel therapeutic target for ccRCC treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The pituitary tumor transforming gene (PTTG1) is an oncogene involved in various cancers.
- Clear cell renal cell carcinoma (ccRCC) is characterized by specific chromosomal abnormalities, including 5q amplifications of unclear significance.
- PTTG1 is located in the 5q region amplified in ccRCC.
Purpose of the Study:
- To investigate the functional role of PTTG1 in ccRCC tumorigenesis.
- To determine the clinical significance of PTTG1 amplification and overexpression in ccRCC.
- To identify potential therapeutic targets within the PTTG1 pathway in ccRCC.
Main Methods:
- Analysis of PTTG1 amplification and expression in ccRCC tumor tissues.
- Assessment of PTTG1's role in ccRCC progression using preclinical models.
- Gene expression analysis to identify PTTG1-regulated genes and pathways.
- Correlation of PTTG1 and ECT2 expression with clinical features and patient prognosis.
Main Results:
- PTTG1 was found to be amplified and overexpressed in ccRCC tumors.
- PTTG1 amplification and overexpression correlated with high tumor grade and poor patient prognosis.
- PTTG1 ablation in preclinical models reduced ccRCC tumorigenesis and invasion.
- PTTG1 influences the expression of ECT2, a proto-oncogene associated with invasive disease.
Conclusions:
- PTTG1 acts as an oncogene in ccRCC, driven by amplification on chromosome 5q.
- PTTG1 expression is linked to aggressive tumor characteristics and poor outcomes.
- PTTG1 and its downstream target ECT2 represent potential novel therapeutic targets for ccRCC.
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation
